Navigation Links
New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
Date:9/19/2008

ld's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, General Medicine, which includes Cardiology and Primary Care and Specialty Medicine, which includes Hematology, Oncology and Multiple Sclerosis. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

Forward-Looking Statements

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports to the Frankfurt Stock Exchange and in our reports filed with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

* WCTRIMS is the first joint meeting of ECTRIMS (the European Committee on Treatment and Research in Multiple Sclerosis) and its counterparts in North and Latin America: ACTRIMS and LACTRIMS

(i) DS Goodin, G Ebers, AT Reder, et al. Early Treatment with Interferon Beta-1b is Associated with Improved Long-Term Outcome in Multiple Sclerosis. World Congress on Treatment and Research in Multiple Sclerosis 2008.

(ii) S Fredrikson, DW Langdon, K Kim, et al. Cognition, Fatigue, Depression and Health-Related Quality of Life in Early Multiple Sclerosis: Baseline Data from CogniMS, a Multinational Longitudinal Study. World Congress on Tre
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium
2. Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008
3. TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet
4. Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008
5. First Ever Study on Alzheimers Disease Treatment in Hispanics Presented at Major Medical Meeting
6. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
7. Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
8. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
9. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
10. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
11. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 2014 Reportbuyer.com has added a new ... Lasers and Energy Devices Market Outlook to 2020, ... Brazil Aesthetic Lasers and Energy Devices Market ... GlobalData,s new report, "Brazil Aesthetic Lasers and ... market data on the Brazil Aesthetic Lasers and ...
(Date:9/1/2014)... YORK , Sept. 1, 2014 ... market research report is available in its catalogue: ... 2014 - 2024 http://www.reportlinker.com/p02280919/Antibody-Drug-Conjugates-Market-2nd-Edition-2014---2024.html ... (ADCs) are a new class of therapeutic agents, ... pharmaceutical companies. Generally addressed as the marriage of ...
(Date:9/1/2014)... Reportlinker.com announces that a new market ... Drug Discovery Technologies - A Global Market Overview ... The development of new drugs for treating ... in addition to consuming a lot of time. ... involves the utilizing high-throughput screening of large chemical ...
Breaking Medicine Technology:Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 2Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 3Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 4Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 5Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 6Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 7Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 8Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 9Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 10Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 11Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 12Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 13Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 14Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 15Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 16Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 17Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024 18Drug Discovery Technologies - A Global Market Overview 2Drug Discovery Technologies - A Global Market Overview 3Drug Discovery Technologies - A Global Market Overview 4Drug Discovery Technologies - A Global Market Overview 5Drug Discovery Technologies - A Global Market Overview 6Drug Discovery Technologies - A Global Market Overview 7Drug Discovery Technologies - A Global Market Overview 8Drug Discovery Technologies - A Global Market Overview 9Drug Discovery Technologies - A Global Market Overview 10Drug Discovery Technologies - A Global Market Overview 11
... YORK, Dec. 8, 2010 Reportlinker.com announces that ... its catalogue: Global Generic Pharmaceuticals ... The Global Generic Pharmaceuticals Industry Report ... evaluation of the Global Generic Pharmaceuticals Industry Report. ...
... Ill., Dec. 8, 2010 Life Spine announced today ... the OCTAVE Posterior Fusion System, which is intended for ... achieving fusion in conjunction with bone graft. The U.S. ... to the OCTAVE System last month. ...
Cached Medicine Technology:Reportlinker Adds Global Generic Pharmaceuticals Industry Report 2Reportlinker Adds Global Generic Pharmaceuticals Industry Report 3Reportlinker Adds Global Generic Pharmaceuticals Industry Report 4Reportlinker Adds Global Generic Pharmaceuticals Industry Report 5Reportlinker Adds Global Generic Pharmaceuticals Industry Report 6Reportlinker Adds Global Generic Pharmaceuticals Industry Report 7
(Date:9/1/2014)... drilled, fitted with a hand pump, and a community ... time? Half of them break down in a year. ... training, these wells would be rendered unusable; however, a ... (UNC) Water Institute and Water and Sanitation for Africa, ... communities collect fees for repairs and train community members ...
(Date:9/1/2014)... cannabis commonly known as marijuana is ... Massachusetts General Hospital (MGH) investigators found that 40 ... substance use disorder reported experiencing symptoms of withdrawal, ... Study participants reporting withdrawal were more likely ... for mood disorders, although the presence or absence ...
(Date:9/1/2014)... a professional company of women’s dresses and related accessories, ... evening dresses . In addition, the company is now ... All customers can enjoy a big discount, up to ... is one of the leading suppliers in the global ... to create more trendy items. The company's aim is ...
(Date:9/1/2014)... “Australia Hernia Repair Market Outlook to 2020? provides ... The report provides value, in millions of US dollars, ... within market segments –,     Synthetic Meshes ...     Composite Meshes and Biological Meshes. , Hernia ... of a hernia (a bulging of internal organs or ...
(Date:9/1/2014)... News) -- Having regular family meals may help protect ... a new study suggests. Online abuse can lead ... "One in five adolescents experience cyberbullying," Frank Elgar, ... Policy at McGill University in Montreal, said in a ... and online harassment and abuse are difficult for parents ...
Breaking Medicine News(10 mins):Health News:The key to drilling wells with staying power in the developing world 2Health News:The key to drilling wells with staying power in the developing world 3Health News:Cannabis withdrawal symptoms common among adolescents treated for substance use disorder 2Health News:Cannabis withdrawal symptoms common among adolescents treated for substance use disorder 3Health News:iFitDress.com: New Modest Evening Wear Selection Now Unveiled Online 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 3Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 4Health News:Family Meals May Defuse Cyberbullying's Impact, Study Says 2
... discontinuing HIV drug therapy and then restarting it as and ... study. New England Journal of Medicine has published the results ... the treatment is discontinued, the patients face a greater chance ... side effects of the anti retro viral drugs that are ...
... rooms not only increase patient privacy but also ... a// University of Florida study. ,The study ... when compared with open-bay, double-occupancy and combination configurations ... has separate rooms for each infant, while the ...
... fortified with specific micronutrients—zinc, iron, selenium, copper, vitamin ... and acute lower// respiratory illness among children in ... Hopkins Bloomberg School of Public Health and the ... India. The study was published November 28, 2006, ...
... robotically assisted laparoscopic surgeries. A robot can easily ... body. Laparoscopic surgeons at// UT Southwestern Medical Center ... surgeries. , Laparoscopic surgeries, are performed ... incision. This usually results in fewer complications, shorter ...
... Ministry of Health and Family Welfare is procuring a ... 100 beds would// have state of art operation theatre, ... unit and its own power generator. ,This ... and can be transported by road, rail or air ...
... spacer between lumbar vertebrae during a procedure called ... minimally invasive way to treat spinal// stenosis, according ... published by ECRI, an independent nonprofit health services ... devices, drugs, biotechnologies, procedures, and health services. ...
Cached Medicine News:Health News:Interrupted Treatment Dangerous to HIV Management 2Health News:Staffers Benefit from Single-Room Design for Baby Care 2Health News:Fortified Milk Reduces Morbidity in Preschool Children 2Health News:North Texas Surgeons Lead Robotically Assisted Laparoscopic Surgeries. 2Health News:Spacer Insertion May Offer Less Invasive Option for Lumbar Problems 2Health News:Spacer Insertion May Offer Less Invasive Option for Lumbar Problems 3
Designed for simple operation, the Model 515C pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
A software program for simple, efficient pulse oximetry analysis, which enables easy viewing, analysis and report generation for pulse rate and SpO 2 ....
... for an emergency situation, bedside monitoring or ... / Pulse Oximeter delivers accurate SpO 2 ... handheld monitor now contains Nellcors latest OxiMax ... OxiMax sensors. The NPB-75 monitor also features ...
... N-20PA Handheld Pulse Oximeter is a one-of-a-kind ... construction of the N-20PA has been shock-tested, ... conditions it has even withstood the ... portable for spot check measurements and also ...
Medicine Products: